Correlation of lipids and lipoprotein concentration with body mass index in obese, overweight and normal weight south Indian adults
DOI:
https://doi.org/10.18203/2320-6012.ijrms20174923Keywords:
Body mass index, Cardiac risk, ObesityAbstract
Background: Obesity a chronic disorder is gradually becoming a serious public health problem in many countries. The aim of the study was designed to measure serum lipids and lipoproteins as marker for cardiovascular disease among obese and overweight South Indian adults.
Methods: The study was done between June 2016 to December 2016, in SRM medical college hospital and research centre, Kattankulathur which comprised of 270 participants of both gender in the age of 18- 55 years. 90 individuals with body mass index (BMI ≥25kg/m2), 90 individuals with BMI in the range of 23.0 to 24.99kg/m2 and 90 age and sex matched controls (BMI = 18 to 22.99kg/m2) were selected for the study. Serum levels of total cholesterol, Triacylglycerol, high density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) were analyzed by using auto analyzer Beckman Coulter AU480. The cardiac risk ratio 1 (cholesterol/HDL-C ratio) and 2 (LDL-C/HDL-C) ratio were calculated.
Results: The difference between the mean values of total cholesterol, triglycerides and LDL-C, were found to be statistically significant across the three groups. Positive correlation was observed between BMI and cardiac risk ratios one and two in both obese and overweight groups.
Conclusions: Cardiac risk is increased in South Indian overweight and obese individuals which is evident from the elevated levels of total cholesterol, triglycerides, LDL-C and cardiac rick ratio one (cholesterol/HDL-C ratio) and two (LDL-C/HDL-C).
References
Pomerleau J, McKee M, Lobstein T, Knai C. The burden of disease attributable to nutrition in Europe. Public Health Nut. 2003;(6):453-61.
World Health Organization. Study group on diabetes mellitus, 1985;727. Available at http://apps.who.int/iris/bitstream/10665/39592/1/WHO_TRS_727.pdf.
McGill HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105(23):2712-8.
Oben JE, Enyegue DM, Ngondi JL, Fomekong GI, Agbor GA. Oxidative stress and blood lipid profile in cameroonian obese subjects. Sunway Academic J. 2008;5:149-55.
Chadha DS, Singh G, Kharbanda P, Vasdev V, Ganjoo RK. Anthropometry Correlation of Lipid Profile in Healthy Aviators. Ind J Aerospace Medic. 2006;50(2):32-6.
Zarghami N, Malekim J, Mamaghani F, Mohammadzadeh GM. Correlation between leptin serum levels with lipid profile and anthropometric indices in women with different grades of obesity.Journal of Zanjan University of Medical Sciences and Health Services. 2010;(18):13-24.
Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, et al. Reassessment of body mass indices. Am J Cl Nutr. 1990;(52):405-8.
Ugwuja EI, Ogbonna NC, Nwibo AN, Onimawo IA. Overweight and obesity, lipid profile and atherogenic indices among civil servants in Abakaliki, South Eastern Nigeria. Anna Medic Heal Sci Res. 2013;3(1):13-8.
Burstein M, Scholnic HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11(6):583-95.
Kalra S, Unnikrishnan AG. Obesity in India: The weight of the nation. J Medic Nutri Nutra. 2012;1(1):37.
Strauss RS. Childhood obesity. Pedi Clin North Am. 2002;49(1):175-201.
Khoury M, Manlhiot C. Role of waist measures in characterizing the lipid and blood pressure assessment of adolescents classified by BMI. Arch Pedi Adolescent Medic. 2012;166(8):719-72.
Plaurde G. Impact of obesity on glucose and lipid profile in adolescents at different age groups in relation to adulthood. BMC Family Practice. 2002;3:18.
Anderson KM, Wilson PW, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample The Framingham offspring study. Atherosclerosis. 1987;68(1-2):59-66.
Newman B, Selby JV. Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health. 1990;80:675-8.
Bertsias G, Mammas I, Linardakis M, Kafatos A. Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC public health. 2003;3(1):3.
Kannel WB, Lebauer EJ. Relation of body weight to development of coronary heart disease: the Framingham Study. Circulation. 1967;35:734-44.
Howard BV, Knowler WC. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis. 1984;4:462-71.
Uusitupa M, Siitonen O. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL cholesterol and triglyceride levels. Diab Care. 1986;9:17-22.
Jousilahti P, Tuomilehto J. Body Weight, Cardiovascular risk factors, and coronary mortality. 15-Year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372-9.
Reeder BA, Angel A, Ledoux M. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ. 1992;146:2009-19.
Rifkind BM, Begg T. Relationship of plasma lipids and lipoproteins to obesity. Proc R So Med. 1966;59:1277-8.
Angel A. Pathophysiologic changes in obesity. CMAJ. 2005;23:421-9.
Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses arteriosclerosis, thrombosis, and vascular biology. Art Th Vas Bio. 1997;17:1082-90.
Panagiotakos DB, Pitsavos C. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA Study. Obes Res. 2004;12:1914-20.
Denke MA, Sempos CT. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch of Int Med. 1993;153:1093-103.
Carroll MD, Lacher DA. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005; 294:1773-81.
Bays H. Atherogenic dyslipidemia in type 2 diabetes and metabolic syndrome: current and future treatment options. Br J Diabetes Vas Dis. 2003; 3:356-60.
